The Association for the Advancement of Blood & Biotherapies (AABB) is proud to introduce the AABB Biotherapies Corporate Membership Program, an initiative designed to ease challenges that biotherapies companies face, including workforce development, quality systems control and regulatory support.
AABB’s new Biotherapies Corporate Membership was developed to be an essential resource for biotech companies looking to accelerate their speed to market. Key benefits of the membership include:
- A consulting package featuring insight and guidance from AABB’s world-renowned expert consultants.
- Access to all AABB content and communities for five individual members at each member organization.
- An invitation to join subspecialty working groups, which bring together leaders in the field from throughout the world. These groups focus on specific issues or needs within the field and offer the opportunity for members to learn, share knowledge and best practices, and develop resources to advance the field.
- Access to AABB’s curated biotherapies library, comprising exclusive products and resources that have been curated or created by experts, all with a specific focus on the benefit they offer to professionals in the biotherapies field. The library comprises expert-developed training programs with a biotherapies focus, including AABB’s popular Cellular Therapies Certificate Program, Flow Cytometry Course, and a new course: Foundations in Cell Therapy. Other highlights include quality management systems resources, such as AABB standards and accreditation tools, as well as key publications. AABB is continuing to expand the resource library and will be developing and adding additional highly relevant content for members throughout 2023.
- Free global job board postings.
- Corporate logo posted on AABB website and year-round promotion in AABB collateral.
- Corporate marketing kit to promote your organizational membership.
